These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 16923394)

  • 21. Involvement of PU.1 in the transcriptional regulation of TNF-alpha.
    Fukai T; Nishiyama C; Kanada S; Nakano N; Hara M; Tokura T; Ikeda S; Ogawa H; Okumura K
    Biochem Biophys Res Commun; 2009 Oct; 388(1):102-6. PubMed ID: 19646961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular pathways regulating the self-renewal of hematopoietic stem cells.
    Stein MI; Zhu J; Emerson SG
    Exp Hematol; 2004 Dec; 32(12):1129-36. PubMed ID: 15588937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective.
    Rajasekhar VK; Begemann M
    Stem Cells; 2007 Oct; 25(10):2498-510. PubMed ID: 17600113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A bistable genetic switch which does not require high co-operativity at the promoter: a two-timescale model for the PU.1-GATA-1 interaction.
    Bokes P; King JR; Loose M
    Math Med Biol; 2009 Jun; 26(2):117-32. PubMed ID: 19181622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of B lymphocyte and macrophage development by graded expression of PU.1.
    DeKoter RP; Singh H
    Science; 2000 May; 288(5470):1439-41. PubMed ID: 10827957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gfi1 and Gfi1b: key regulators of hematopoiesis.
    van der Meer LT; Jansen JH; van der Reijden BA
    Leukemia; 2010 Nov; 24(11):1834-43. PubMed ID: 20861919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells.
    Chinen H; Matsuoka K; Sato T; Kamada N; Okamoto S; Hisamatsu T; Kobayashi T; Hasegawa H; Sugita A; Kinjo F; Fujita J; Hibi T
    Gastroenterology; 2007 Aug; 133(2):559-73. PubMed ID: 17681176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
    Kastner P; Chan S
    Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
    Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
    Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates.
    Walsh JC; DeKoter RP; Lee HJ; Smith ED; Lancki DW; Gurish MF; Friend DS; Stevens RL; Anastasi J; Singh H
    Immunity; 2002 Nov; 17(5):665-76. PubMed ID: 12433372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells.
    Sarrazin S; Mossadegh-Keller N; Fukao T; Aziz A; Mourcin F; Vanhille L; Kelly Modis L; Kastner P; Chan S; Duprez E; Otto C; Sieweke MH
    Cell; 2009 Jul; 138(2):300-13. PubMed ID: 19632180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of Pu.1 by small interfering RNA in CD34+ embryoid body cells derived from mouse ES cells turns cell fate determination to pro-B cells.
    Zou GM; Chen JJ; Yoder MC; Wu W; Rowley JD
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13236-41. PubMed ID: 16141339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A panorama of lineage-specific transcription in hematopoiesis.
    Kluger Y; Lian Z; Zhang X; Newburger PE; Weissman SM
    Bioessays; 2004 Dec; 26(12):1276-87. PubMed ID: 15551261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate.
    Bakri Y; Sarrazin S; Mayer UP; Tillmanns S; Nerlov C; Boned A; Sieweke MH
    Blood; 2005 Apr; 105(7):2707-16. PubMed ID: 15598817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage.
    Nguyen HQ; Hoffman-Liebermann B; Liebermann DA
    Cell; 1993 Jan; 72(2):197-209. PubMed ID: 7678779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate.
    Chou ST; Khandros E; Bailey LC; Nichols KE; Vakoc CR; Yao Y; Huang Z; Crispino JD; Hardison RC; Blobel GA; Weiss MJ
    Blood; 2009 Jul; 114(5):983-94. PubMed ID: 19491391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PU.1, a shared transcriptional regulator of lymphoid and myeloid cell fates.
    Singh H; DeKoter RP; Walsh JC
    Cold Spring Harb Symp Quant Biol; 1999; 64():13-20. PubMed ID: 11232277
    [No Abstract]   [Full Text] [Related]  

  • 38. A recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates.
    Spooner CJ; Cheng JX; Pujadas E; Laslo P; Singh H
    Immunity; 2009 Oct; 31(4):576-86. PubMed ID: 19818654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AML-1 steps up to the platelets.
    Irvin BJ; Hiebert SW
    Nat Med; 2004 Mar; 10(3):238-9. PubMed ID: 14991045
    [No Abstract]   [Full Text] [Related]  

  • 40. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages.
    Scott EW; Simon MC; Anastasi J; Singh H
    Science; 1994 Sep; 265(5178):1573-7. PubMed ID: 8079170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.